Diastolic heart failure: The forgotten manifestation of hypertensive heart disease

被引:0
|
作者
Rigobert Lapu-Bula
Elizabeth Ofili
机构
[1] Morehouse School of Medicine,Division of Cardiology, Department of Medicine
来源
Current Hypertension Reports | 2004年 / 6卷
关键词
Diastolic Dysfunction; Diastolic Function; Myocardial Blood Flow; Candesartan; Left Ventricular Filling;
D O I
暂无
中图分类号
学科分类号
摘要
Heart failure (HF) is a progressively debilitating disorder characterized by frequent hospital admissions and high annual mortality rates. Coronary artery disease (CAD), hypertension, and aging are major risk factors for the development/ progression of HF. For years, most of the attention has been focused on HF caused by reduced left ventricular (LV) systolic function, largely attributable to CAD. It is now generally accepted that nearly 50% of elderly patients with HF might have normal or preserved LV systolic function. This condition is commonly referred to as a distinct type of HF caused by LV diastolic dysfunction, and it often accompanies hypertensive heart disease. Isolated diastolic HF is increasingly recognized as the dominant cause of symptoms and hospitalizations from HF in a large proportion of individuals aged 65 and older. However, the clinicians caring for patients with diastolic HF do not fully understand its cause, how it progresses, or how it could be appropriately diagnosed and treated. Because varying degrees of systolic and diastolic dysfunction might coexist in any individual patient, and given the limitation of current diagnostic tools, the overall impact of isolated diastolic HF continues to evolve. Ongoing clinical trials are testing new strategies for treatment of diastolic HF.
引用
收藏
页码:164 / 170
页数:6
相关论文
共 50 条
  • [31] Diastolic heart failure: Incidence, diagnosis, therapy
    Breuer, HWM
    HERZ KREISLAUF, 1999, 31 (7-8): : 277 - 282
  • [32] Diastolic Heart Failure in the Elderly and the Potential Role of Aldosterone Antagonists
    Ashwani Kumar
    Gary Meyerrose
    Vineeta Sood
    Chanwit Roongsritong
    Drugs & Aging, 2006, 23 : 299 - 308
  • [33] Diastolic heart failure: recognition, diagnosis and management
    Goyal, D
    Choudhary, A
    Lip, GYH
    MacFadyen, RJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1745 - 1754
  • [34] Imaging in hypertensive heart disease
    Janardhanan, Rajesh
    Kramer, Christopher M.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (02) : 199 - 209
  • [35] EFFECT OF CHRONIC KIDNEY DISEASE ON THE FORMATION OF DIASTOLIC HEART DYSFUNCTION IN HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION
    Kuzmin, O. B.
    Zhezha, V. V.
    Belyanin, V. V.
    Buchneva, N., V
    KARDIOLOGIYA, 2018, 58 : 37 - 45
  • [36] Heart failure in congenital heart disease: the role of genes and hemodynamics
    Vanderlaan, Rachel D.
    Caldarone, Christopher A.
    Backx, Peter H.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2014, 466 (06): : 1025 - 1035
  • [37] Myofilament Phosphorylation in Experimental Diastolic Heart Failure
    Bishu, Kalkidan
    Ogut, Ozgur
    Mohammed, Selma F.
    Brozovich, Frank V.
    Redfield, Margaret M.
    CIRCULATION, 2011, 124 (21)
  • [38] Diastolic Dysfunction Criteria and Heart failure Readmission in Patients with Heart Failure and Reduced Ejection Fraction
    Lavine, Steven J.
    Kelvas, Danielle
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2023, 17
  • [39] Diastolic Dysfunction Criteria and Heart failure Readmission in Patients with Heart Failure and Reduced Ejection Fraction
    Lavine, Steven J.
    Kelvas, Danielle
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2023, 17
  • [40] Left Ventricular Diastolic Dysfunction and Diastolic Heart Failure in Preterm Infants
    Koert de Waal
    Nicholas Costley
    Nilkant Phad
    Edward Crendal
    Pediatric Cardiology, 2019, 40 : 1709 - 1715